MIRA INFORM REPORT

 

 

Report Date :

29.06.2011

 

IDENTIFICATION DETAILS

 

Name :

UNJHA PHARMACEUTICALS PRIVATE LIMITED

 

 

Registered Office :

Unjha Pharmacy Building, Dhanvantary Prasad, Station Road, Unjha, Mehsana – 384170, Gujarat

 

 

Country :

India

 

 

Financials (as on) :

31.03.2010

 

 

Date of Incorporation :

20.11.2000

 

 

Com. Reg. No.:

04-038943

 

 

Capital Investment / Paid-up Capital :

Rs.0.450 Millions

 

 

CIN No.:

[Company Identification No.]

U24134GJ2000PTC038943

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

AHMU00412G

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Ayurvedic Medicines, Medicines and Pharmaceutical Products.

 

 

No. of Employees :

150 [in office] Approximately

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (26)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 30000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate trade. Profitability of the company appears to be low. However, trade relations are reported as fair. Business is active. Payments are reported to be slow.

 

The company can be considered for business dealings with some caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 30, 2010

 

Country Name

Previous Rating

(01.04.2010)

Current Rating

(30.06.2010)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

 

INFORMATION PARTED BY

 

Name :

Mr. Vishnu Patel

Designation :

General Manager

Contact No.:

91-9327007448

Date :

17.06.2011

 

 

LOCATIONS

 

Registered Office / Factory 1 :

Unjha Pharmacy Building, Dhanvantary Prasad, Station Road, Unjha, Mehsana – 384170, Gujarat India

Tel. No.:

91-79-26858563 / 26858683 / 26858491

Mobile No.:

91-9327007448 (Mr. Vishnu Patel)

Fax No.:

91-79-26858563 / 26858491

E-Mail :

Lkshah_ca@sify.com

uppl@icenet.net

unjhapharma_corp@yahoo.co.in

Website :

http://www.unjhapharmacy.com

Area :

25000 Sq.ft.

Location :

Owned

 

 

Corporate Office :

805, Avdhesh, Opposite Gurudwara, Sarkheja-Gandhinagar Highway, Bodakdev, Ahmedabad - 380054, Gujarat, India

Area :

3500 Sq.ft.

Location :

Owned

 

 

Factory 2 :

215, Kamalavilla, Chatralkadi Road, Dudasana, Kadi - 382721, Gujarat, India

Area :

105000 Sq.ft.

Location :

Owned

 

 

Branches :

Located at

  • Rajasthan
  • Pune, Maharashtra
  • Indore
  • Chhatishgarh
  • Andhra Pradesh

 

 

DIRECTORS

 

As on 29.09.2010

 

Name :

Mr. Jashvant Bhogilal Shah

Designation :

Director

Address :

Bodhida, Near Gokul Hotel, Sarkhej-Gandhinagar Highway, Gota, Ahmedabad-382481, Gujarat, India

Date of Birth/Age :

58 Years

Qualification :

B. Com

Date of Appointment :

20.11.2000

DIN :

00442510

 

 

Name :

Mrs. Shobhana Jashvant Shah

Designation :

Director

Address :

Bodhida, Near Gokul Hotel, Sarkhej-Gandhinagar Highway, Gota, Ahmedabad-382481, Gujarat, India

Date of Birth/Age :

55 Years

Qualification :

B. Com

Date of Appointment :

20.11.2000

DIN :

00443269

 

 

KEY EXECUTIVES

 

Name :

Mr. Vishnu Patel

Designation :

General Manager

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 29.09.2010

 

Names of Shareholders

 

No. of Shares

Jashvant Bhogilal Shah

 

21600

Shobhana Jashvant Shah

 

16900

Malav Jashvant Shah

 

3500

Gatha Jashvant Shah

 

2500

Jashvant Bhogilal Shah (HUF)

 

500

 

 

 

Total

 

45000

 

As on 29.09.2010

 

Category

 

Percentage

 

 

 

Directors or relatives of directors

 

100.00

 

 

 

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Ayurvedic Medicines, Medicines and Pharmaceutical Products.

 

 

Products :

  • Ayurvedic Medicine
  • Ayurvedic Products
  • Ayurvedic Tablet
  • Syrup Tablet
  • Syrup
  • Chyvanprash
  • Avleha
  • Raerasayan
  • Quath
  • Shishu Sanjivani
  • Arogyavaedhini Rasa
  • Arshoghni Vati
  • Chandrakala Ras
  • Ekangvir Ras
  • Navayasa Churna
  • Savtantra Churna

 

 

Terms :

 

Selling :

Credit [30 / 60 Days]

 

 

Purchasing :

Credit [30 / 60 Days]

 

 

GENERAL INFORMATION

 

Customers :

  • Wholesalers
  • Retailers

 

 

No. of Employees :

150 [in office] Approximately

 

 

Bankers :

  • Axis Bank Limited, Trishul, 3rd Floor, Opposite Samartheshwar Temple, Law Garden Ellisbridge, Ahmedabad - 380006, Gujarat, India
  • State Bank of India, Ahmedabad

 

 

Facilities :

Total Facility Enjoyed – Rs.35.000 millions (from Axis Bank Limited)

 

Particulars

31.03.2010

31.03.2009

Secured Loans (Rs. In Millions)

 

 

From State Bank of India FD OD A/c

0.000

1.041

Axis bank Loan A/c

11.000

0.000

Axis bank Loan CC A/c

9.662

0.000

Total

20.662

1.041

 

Unsecured Loan [Rs. in million]

31.03.2010

31.03.2009

From Directors

4.053

5.545

From Directors

30.061

23.296

Security Deposit

0.504

0.317

Advances From others

0.879

6.664

Total

35.497

35.822

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

L. K. Shah and Company

Chartered Accountant 

Address :

814, ATMA House, Opposite LA. Gajjar Chambers, Ashram Road, Ahmedabad-380009, Gujarat, India

Tel. No. :

91-79-26583078

Fax No. :

91-79-27438143

 

 

Associates/Subsidiaries :

Aura Neutracitical Limited

Line of Business: Manufacturer of Pharmaceutical Products.

Address: 805, Avdhesh, Opposite Gurudwara, Sarkheja-Gandhinagar Highway, Bodakdev, Ahmedabad-380054, Gujarat, India

 

Arcadia Mercantile Capital Limited

CIN : L65910GJ1997PLC033191

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2010

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

50,000

Equity Share

Rs.10/- Each

Rs.0.500 million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

45,000

Equity Share

Rs.10/- Each

Rs.0.450 million

 

 

 

 

 


 

FINANCIAL DATA

[All figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2010

31.03.2009

31.03.2008

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

0.450

0.350

0.100

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

7.107

2.439

0.011

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

7.557

2.789

0.111

LOAN FUNDS

 

 

 

1] Secured Loans

20.662

1.041

0.760

2] Unsecured Loans

35.497

35.822

26.245

TOTAL BORROWING

56.159

36.863

27.005

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

63.716

39.652

27.116

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

1.466

1.503

1.726

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.013

1.350

1.269

DEFERREX TAX ASSETS

0.167

0.166

0.161

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

25.794
16.398
0.997

 

Sundry Debtors

33.419
27.242
22.419

 

Cash & Bank Balances

4.019
0.040
0.060

 

Other Current Assets

0.000
0.000
0.000

 

Loans & Advances

8.528
1.677
2.109

Total Current Assets

71.760
45.357
25.585

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Current Liabilities

0.265
0.031
1.260

 

Sundry Creditors

8.418
7.947
--

 

Provisions

1.007
0.746
0.365

Total Current Liabilities

9.690
8.724
1.625

Net Current Assets

62.070
36.633
23.960

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

63.716

39.652

27.116

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2010

31.03.2009

31.03.2008

 

 

 

 

 

 

TURNOVER

40.154

14.382

4.895

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION

0.649

NA

0.226

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

0.255

NA

0.375

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

0.394

0.236

[0.149]

 

 

 

 

 

Less

TAX                                                                  (I)

0.127

0.057

0.009

 

 

 

 

 

 

PROFIT AFTER TAX (G-I)                                  (J)

0.267

0.179

[0.158]

 

 

 

 

 

 

Earnings Per Share (Rs.)

5.95

5.10

--

 

Expected Sales (2010-11): Rs.65.000 millions

 

The above information has been parted by Mr. Vishnu Patel [General Manager]

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2010

31.03.2009

31.03.2008

PAT / Total Income

(%)

0.66                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

1.24

(3.23)

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

0.54

0.50

(0.55)

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.05

0.08

(1.34)

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

8.71

16.35

257.93

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

7.40

5.20

15.74

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Trade References :

 

  • Mahavir Enterprises - Ahmedabad
  • Modern Plast Mould – Chhatral Mehsana Highway

 

Financial Results and Operations

 

The accounts (or the period under report show a net Profit of Rs 0.394 million at against the ineviow yaw's Profit of Rs 0.236 million after providing depreciation of Rs.0.255 million and before providing Income Tax provision of Rs 0.128 million und deferred tax assets of Rs.0.001 million. The total net profit of Rs 0.267 million is earned over to that Balance sheet.

 

Bankers Charges Report as per Registry

 

Corporate identity number of the company

U24134GJ2000PTC038943

Name of the company

Unjha Pharmaceuticals Private Limited

Address of the registered office or of the principal place of  business in India of the company

Unjha Pharmacy Building, Dhanvantary Prasad, Station Road, Unjha, Mehsana-384170, Gujarat, India

This form is for

Modification of Charge

Charge identification (ID) number of the charge to be modified

10209524

Type of charge

  • Book Debts
  • Movable Property
  • Others

Particular of charge holder

Axis Bank Limited, Trishul, 3rd Floor, Opposite Samartheshwar Temple, Law Garden Ellisbridge, Ahmedabad-380006, Gujarat, India

Emil ID: cmchead.ahmedabad@axisbank.com

Nature of instrument creating charge

Supplemental Deed Of Hypothecation

Date of instrument Creating the charge

31.12.2010

Amount secured by the charge

Rs.24.284 millions

Brief of the principal terms an conditions and extent and operation of the charge

Rate of Interest - Base Rate + 5.00% i.e. 12.75 % p.a. with monthly rest12 months

 

Terms of Repayment - 12 months

 

Margin - As Per Sanction Letter And Agreement

 

Extent and Operation of the charge - The Charge Will Operate As First Charge On  The Entire Current Assets Of The Company.

Short particular of the property or asset(s) charged

All The Stock In Trade Both Present And Future Consisting Stock Including Raw Materials, Stock In Process, Finished Goods, Cash, Bd And Other Current Assets Whatsoever, Being Moveable Properties .

Particulars of the present modification

The Limit Of Operation Of The Charge Has Been Enhanced From Rs.20.000 millions To Rs. 24.284 million (Od (Mpower Od) Rs.14.000 millions And Tl(Mpower Tl) Rs. 10.284 millions)

 

FIXED ASSETS :

·         Computer

·         Motor Car

·         Motor Cycle and Scooter

·         Trade Mark

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.45.05

UK Pound

1

Rs.71.91

Euro

1

Rs.64.34

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

2

--PROFITABILIRY

1~10

2

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

2

--CREDIT LINES

1~10

3

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

26

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.